Health & bio
Veppanu FDA Approved; First-in-Class Protein Degrader for Breast Cancer
On May 1, FDA approved Veppanu for ER+/HER2-/ESR1-mutant advanced breast cancer. Protein degradation mechanism is key.
Primary sources · 1
Related storylines
On May 1, FDA approved Veppanu for ER+/HER2-/ESR1-mutant advanced breast cancer. Protein degradation mechanism is key.
7 must-reads · 17 fields · tracked storylines delivered to your inbox daily. Pick only the fields you want; unsubscribe anytime.